On Wednesday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s PFE Ibrance (palbociclib) regimen for ...
Pfizer (PFE) and Astellas (ALPMF) (ALPMY) announced Monday that the FDA has granted priority review for their marketing application, which seeks U.S. approval for their antibody drug conjugate, Padcev ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results